Mari Lahnalampi
Väitöskirjatutkija
Biolääketieteen yksikkö, Lääketieteen laitos, Terveystieteiden tiedekunta
mari.lahnalampi@uef.fi | 050 470 1891
Tutkimusryhmät
Julkaisut
7/7 kappaletta-
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
Gentile, Gaia; Poggio, Teresa; Catalano, Antonella; Voutilainen, Minna; Lahnalampi, Mari; Andrade-Martinez, Marta; Ma, Tobias; Sankowski, Roman; Goncharenko, Lina; Tholen, Stefan; Han, Kyuho; Morgens, David W.; Prinz, Marco; Lübbert, Michael; Engel, Sophia; Hartmann, Tanja Nicole; Cario, Gunnar; Schrappe, Martin; Lenk, Lennart; Stanulla, Martin; Duyster, Justus; Bronsert, Peter; Bassik, Michael C.; Cleary, Michael L.; Schilling, Oliver; Heinäniemi, Merja; Duque-Afonso, Jesús. 2024. Blood advances. 8: 2846-2860 -
Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia
Malyukova, Alena; Lahnalampi, Mari; Falqués-Costa, Ton; Pölönen, Petri; Sipola, Mikko; Mehtonen, Juha; Teppo, Susanna; Akopyan, Karen; Viiliainen, Johanna; Lohi, Olli; Hagström-Andersson, Anna K; Heinäniemi, Merja; Sangfelt, Olle. 2024. Genome biology. 25: . 143 -
In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolution
Fischer, Anja; Lersch, Robert; de Andrade Krätzig, Niklas; Strong, Alexander; Friedrich, Mathias J.; Weber, Julia; Engleitner, Thomas; Öllinger, Rupert; Yen, Hsi-Yu; Kohlhofer, Ursula; Gonzalez-Menendez, Irene; Sailer, David; Kogan, Liz; Lahnalampi, Mari; Laukkanen, Saara; Kaltenbacher, Thorsten; Klement, Christine; Rezaei, Majdaddin; Ammon, Tim; Montero, Juan J.; Schneider, Günter; Mayerle, Julia; Heikenwälder, Mathias; Schmidt-Supprian, Marc; Quintanilla-Martinez, Leticia; Steiger, Katja; Liu,. 2023. Cell genomics. 3: -
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse
Taavitsainen, S.; Engedal, N.; Cao, S.; Handle, F.; Erickson, A.; Prekovic, S.; Wetterskog, D.; Tolonen, T.; Vuorinen, E. M.; Kiviaho, A.; Nätkin, R.; Häkkinen, T.; Devlies, W.; Henttinen, S.; Kaarijärvi, R.; Lahnalampi, M.; Kaljunen, H.; Nowakowska, K.; Syvälä, H.; Bläuer, M. et al [incl. Ketola, K.]. 2021. Nature communications. 12: 5307 -
SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome
Laukkanen, S; Oksa, L; Nikkilä, A; Lahnalampi, M; Parikka, M; Seki, M; Takita, J; Degerman, S; de Bock, CE; Heinäniemi, M; Lohi, O. 2020. Leukemia & lymphoma. 61: 3089-3100 -
Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities
Mehtonen, Juha; Teppo, Susanna; Lahnalampi, Mari; Kokko, Aleksi; Kaukonen, Riina; Oksa, Laura; Bouvy-Liivrand, Maria; Malyukova, Alena; Mäkinen, Artturi; Laukkanen, Saara; Mäkinen, Petri I; Rounioja, Samuli; Ruusuvuori, Pekka; Sangfelt, Olle; Lund, Riikka; Lönnberg, Tapio; Lohi, Olli; Heinäniemi, Merja. 2020. Genome medicine. 12: Article number: 99 -
Time-resolved expression profiling of the nuclear receptor superfamily in human adipogenesis
Lahnalampi Mari, Heinäniemi Merja, Sinkkonen Lasse, Wabitsch Martin, Carlberg Carsten. 2010. PLoS ONE. 5: -